Using patient-derived B cells, Kling-Select facilitates the rapid detection of new antibodies and preserved viral epitopes.

Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

Kling Bio has announced a new collaboration and licence option agreement with Sanofi to accelerate the discovery of neutralising antibodies using its proprietary B cell platform, Kling-Select.

Dutch privately-held biotech Kling Bio today announced it has entered into a collaboration and license option agreement with French pharma major Sanofi for the discovery of antibodies and epitopes ...

Debbie Kling to step down after eights years of growth, opportunity and challenges as Nampa mayor. Her successor could face issues over growth, funding ...

American depositary receipts of Adagene rose 15% in premarket trading following an investment from Sanofi. ADRs were trading around $2.24. The stock is down 2% on the year. Sanofi agreed to invest ...

The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates put forward by Sanofi.

Adagene Announces Upto $25 Mln Investment From Sanofi, Stock Up In Pre-Market July 01, 2025 — 08:11 am EDT Written by RTTNews.com for RTTNews -> ...

Kymera Therapeutics is celebrating the signing of two partnerships, with Gilead Sciences taking an option on one molecular glue programme, as Sanofi buys into another. The agreement with Gilead ...

San Jose Sharks (@SanJoseSharks) General Manager Mike Grier announced today that the club has signed defenseman John Klingberg to a one-year, $4M contract. Klingberg, 32, is an 11-year NHL veteran ...